Montecito Bank & Trust’s GSK GSK Stock Holding History

Montecito Bank & Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-185	Closed	-$9K	–	267
2016 Q4	$9K	Buy	+185	New	+$9.14K	﹤0.01%	360

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Montecito Bank & Trust's GSK Position: Q1 2017 in Review

Montecito Bank & Trust sold out of GSK (GSK) in Q1 2017, closing a stake of 185 shares — an estimated $9K sold.

Montecito Bank & Trust first reported a position in GSK in Q4 2016 and held it in 1 quarter. The position peaked at $9K in Q4 2016. 786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

Montecito Bank & Trust reported no remaining GSK position as of Q1 2017 after selling out during the quarter.
Montecito Bank & Trust sold 185 GSK shares in Q1 2017, an estimated $9K.
Montecito Bank & Trust first reported a position in GSK in Q4 2016 and held it in 1 quarter.
Montecito Bank & Trust's GSK position peaked at $9K in Q4 2016.
786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on Montecito Bank & Trust's 13F filing for Q1 2017, filed 5 May 2017.